Duomed Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Duomed Group - overview
Established
1993
Location
Aartselaar, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Based in Aartselaar, Belgium, and founded in 1993, Duomed Group operates as a supplier of various healthcare devices, such as endoscopy, surgery, critical care, medical imaging, and physiology monitoring. In April 2024, Palex Medical, SA, a portfolio company of Fremman Capital and Apax Partners, agreed to acquire Duomed from G Square. The company's portfolio includes several divisions, including Duomed Belgium/Luxembourg, Duomed Denmark, Duomed France Endoscopie, Duomed France Solutions, Duomed Southeast Europe, Duomed Sweden, Duomed Switzerland, Duomed The Netherlands, and Duomed UK. As of 2024, the company is led by its CEO, Frederic Hoffmann.
The company provides a wide range of medical devices for surgery (abdominal, vascular, plastic, urology, ortho, and neuro), hospital solutions (anesthesia, infant care, ultrasound, bone densitometry, infection prevention, maternity, consumables & accessories, sterilization equipment, cardiology), and endoscopy (gastroenterology, pulmonology, endoscopic instruments, artificial intelligence, and ultrasonography). Additionally, the firm offers medical device contract research organization (CRO) services for clinical trials through Archer Research and branded products through Vytil.
Current Investors
Capital A
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.duomed.com/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Duomed Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Completed | Launch Diagnostics Limited | - | ||||||||
| Add-on, Trade Sale | Completed | Duomed Group | - | ||||||||
| Add-on | Completed | Mar Medica Ltd. | - | ||||||||
| Add-on | Completed | Dyma Medical | - | ||||||||
| Secondary Buyout | Completed | Duomed Group | - |
Displaying 1 - 5 of 7
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.